Clinical efficacy of dexmedetomidine alone is less than propofol for conscious sedation during ERCP

Gastrointestinal Endoscopy

Volumn 67, Issue 4, 2008, Pages 651-659

  Muller, Suzana ^a   Borowics, Silvia M ^a   Fortis, Elaine A F ^a   Stefani, Luciana C ^a   Soares, Gabriela ^a   Maguilnik, Ismael ^a   Breyer, Helenice P ^a   Hidalgo, Maria Paz L ^a   Caumo, Wolnei ^a  

^a Digestive Endoscopy Unit   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; FENTANYL; PROPOFOL;

ADULT; AGED; ANESTHESIST; APNEA; ARTICLE; BLOOD PRESSURE; BREATHING RATE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN; MALE; MEDICAL SOCIETY; MONOTHERAPY; OXYGEN SATURATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; SEDATION; SIDE EFFECT; SINGLE BLIND PROCEDURE;

ADULT; AGED; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CONSCIOUS SEDATION; DEXMEDETOMIDINE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAVENOUS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; PROPOFOL; TREATMENT OUTCOME;

EID: 41049103127     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2007.09.041     Document Type: Article

References (35)

1. Kremer M.J. Pharmacology. In: Odom-Forren J., and Watson D. (Eds). Practical guide to moderate sedation/analgesia (2005), Elsevier Mosby, St Louis (Mo) 53-80
2. Jowell P.S., Eisen G., Bute B.P., et al. Patient-controlled analgesia for conscious sedation during endoscopic retrograde cholangiopancreatography: a randomized controlled trial. Gastrointest Endosc 43 (1996) 490-494
3. Chen W.X., Lin H.J., Zhang W.F., et al. Sedation and safety of propofol for therapeutic endoscopic retrograde cholangiopancreatography. Hepatobiliary Pancreat Dis Int 4 (2005) 437-40
4. Fanti L., Agostini M., Casati A., et al. Target-controlled propofol infusion during monitored anesthesia in patients undergoing ERCP. Gastrointest Endosc 60 (2004) 361-366
5. Cohen L.B., Hightower C.D., Wood D.A., et al. Moderate level sedation during endoscopy: a prospective study using low-dose propofol, meperidine/fentanyl, and midazolam. Gastrointest Endosc 59 (2004) 795-803
6. Qadeer M.A., Vargo J.J., Kandwala F., et al. Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analysis. Clin Gastroenterol Hepatol 3 (2005) 1049-1056
7. Gurbet A., Basagan-Mogol E., Turker G., et al. Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements. Can J Anaesth 53 (2006) 646-652
8. Hall J.E., Uhrich T.D., Barney J.A., et al. Sedative, amnestic and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 90 (2000) 699-705
9. Lee Y.Y., Wong S.M., and Hung C.T. Dexmedetomidine infusion as a supplement to isoflurane anaesthesia for vitreoretinal surgery. Br J Anaesth 98 (2007) 477-483
10. Tanskanen P.E., Kyttä J.V., Randell T.T., et al. Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery: a double-blind, randomized and placebo-controlled study. Br J Anaesth 97 (2006) 658-665
11. Coursin D.B., and Maccioli G.A. Dexmedetomidine. Curr Opin Crit Care 7 (2001) 221-226
12. Koroglu A., Teksan H., Sagir O., et al. A comparison of the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging. Anesth Analg 103 (2006) 63-67
13. Masur J., and Monteiro M.G. Validation of the "CAGE" alcoholism screening test in a Brazilian psychiatric inpatient hospital setting. Braz J Med Biol Res 16 (1983) 215-218
14. Keats A.S. The ASA classification of physical status: a recapitulation. Anesthesiology 49 (1978) 233-236
15. Schultz S.M., and Abbot R.M. Grading ERCPs by degree of difficulty: a new concept to produce more meaningful outcome data. Gastrointest Endosc 51 (2000) 535-539
16. Ely E.W., Truman B., Shintani A., et al. Monitoring sedation status over time in ICU patients. Reliability and Validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 289 (2003) 2983-2991
17. White H.D. Thrombolytic therapy and equivalence trials. J Am Coll Cardiol 31 (1998) SSP494-SSP496
18. O'Brien P.C., and Fleming T.R. A multiple testing procedure for clinical trial. Biometrics 35 (1979) 549-556
19. Browner W.S., Black D., Newman T.B., et al. Estimating sample size and power. In: Hulley S.B., and Cummings S.R. (Eds). Designing clinical research (1988), Lippincott Williams and Wilkins, Baltimore 139-158
20. Altman D.G. Practical statistic for medical research. 1st ed. (1991), Chapman and Hall, London
21. Sackett D.L., Strauss S.E., Richardson W.S., et al. Therapy. In: Sackett D.L., Strauss S.E., Richardson W.S., et al. (Eds). Evidence-based medicine. 2nd ed. (2000), Churchill Livingstone, London 105-153
22. Venn R.M., Hell J., and Grounds R.M. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 4 (2000) 302-308
23. Scher C.S., and Gitlin M.C. Dexmedetomidine and low-dose ketamine provide adequate sedation for awake fibreoptic intubation. Can J Anaesth 50 (2003) 607-610
24. Arain S.R., Ruehtow R.M., Ulrich T.D., et al. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg 98 (2004) 154-158
25. MacLaren R., Forrest L.K., and Kiser T.H. Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters. Pharmacotherapy 27 (2007) 351-359
26. Jalowiecki P., Rudner R., Gonciarz M., et al. Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy. Anesthesiology 103 (2005) 260-273
27. Arain S., and Ebert T.J. The efficacy, side effects and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg 95 (2002) 461-466
28. Bol C.J.J.G., Vogelaar J.P.W., and Mandema J.W. Anesthetic profile of dexmedetomidine identified by stimulus-response and continuous measurements in rats. J Pharmacol Exp Ther 291 (1999) 153-160
29. Marksimow A.S., Snapir A., Sarkela M., et al. Assessing the depth of dexmedetomidine-induced sedation with electroencephalogram (EEG)-based spectral entropy. Acta Anaesthesiol Scand 51 (2007) 22-30
30. Bhana N., Goa K.L., and McClellan K.J. Dexmedetomidine. Drugs 59 (2000) 263-268
31. Venn M., Newman J., and Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med 29 (2003) 201-207
32. Bekker A.Y., Basile J., Gold M., et al. Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effects. J Neurosurg Anesthesiol 16 (2004) 126-135
33. Stevens R.D., Burri H., and Tramèr M.R. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 97 (2003) 623-633
34. Cazzola M. Application of number needed to treat (NNT) as a measure of treatment effect in respiratory medicine. Treat Respir Med 5 (2006) 79-84
35. Turkmen A., Altan A., Turgut N., et al. The correlation between the Richmond agitation-sedation scale and bispectral index during dexmedetomidine sedation. Eur J Anaesthesiol 23 (2006) 300-304